OPTIMAPHARM CRO Schweiz AG

Address

OPTIMAPHARM CRO Schweiz AG
St. Alban-Anlage 46
4052 Basel



Commercial register ID for OPTIMAPHARM CRO Schweiz AG: CH-100.3.796.216-8

Unique enterprise identification number (UID) for OPTIMAPHARM CRO Schweiz AG: CHE-192.292.207

VAT for OPTIMAPHARM CRO Schweiz AG: CHE-192.292.207 MWST


About the company OPTIMAPHARM CRO Schweiz AG

OPTIMAPHARM CRO Schweiz AG, based in Basel, is a company in Switzerland. OPTIMAPHARM CRO Schweiz AG is active according to the commercial register. The company with the UID number CHE-192.292.207 was founded on 04/29/2013.

For OPTIMAPHARM CRO Schweiz AG, a total of 11 official reports from the Swiss Official Gazette (SOGC) have been published on sogc.help.ch since January 2007. You can see the latest publication by company OPTIMAPHARM CRO Schweiz AG from 08/08/2023 on this link.


Purpose of the company OPTIMAPHARM CRO Schweiz AG

The purpose of the company OPTIMAPHARM CRO Schweiz AG in Basel is as follows. Establishing, acquiring, managing and selling investments of any kind as well as investing and managing capital, specifically in the areas of life sciences or health care; Development of drugs and medical devices (medical devices); Promotion of the Group's business activities in relation to Swiss territory; The company may provide direct or indirect financing to third parties or companies in which it has a direct or indirect interest, as well as direct or indirect shareholders or companies in which they have a direct or indirect interest, whether through loans and / or other financing, including as part of cash pooling agreements; The company can provide collateral of any kind for its own liabilities or the liabilities of the aforementioned persons, including by means of liens, assignments, fiduciary assignments, guarantees of any kind or by means of compensation obligations, whether for consideration or not, even if such financing, collateral or guarantees are exclusively Interests of third parties or companies in which it is directly or indirectly involved, or of direct or indirect shareholders or companies in which they are directly or indirectly involved; Acquisition, administration, encumbrance and sale of land and investments.

Translated by google.com

The company OPTIMAPHARM CRO Schweiz AG in Basel is listed on Yellowpages.swiss. Latitude and longitude coordinates for OPTIMAPHARM CRO Schweiz AG are: 47.5521095 and 7.6005066. The unique identification number of this portrait is CHE-192.292.207.


Data Source: Commercial register, SOGC, FSO
Last update on 08.08.2023


Which companies are available at the same address? In addition to OPTIMAPHARM CRO Schweiz AG, there are other active companies at the same address St. Alban-Anlage 46, 4052 Basel. This includes the companies Bächtiger Liwoba Immobilien AG| Groupe Mutuel - Agentur Basel| Hygienics GmbH.

Info about Basel

The enterprise OPTIMAPHARM CRO Schweiz AG is registered in the city of Basel. Basel is a municipality in the canton of Basle Town. Basle Town is a canton in the German-speaking part of Switzerland. The capital and also the most populous place is Basle. The canton belongs to the economic region of Northwestern Switzerland and the cross-border metropolitan region of Basle. The canton of Basle Town is one of 26 cantons in the Swiss Confederation.

The locality Basel is located in the canton of Basle Town in Switzerland country, in Europe continent. Latitude and longitude coordinates for Basel are: 47.5595986 and 7.5885761. The local date and time in Basel is 05/28/2024, 9:23 PM.

The information on this entry in the commercial register of the legal entity OPTIMAPHARM CRO Schweiz AG is provided without guarantee and has no legal effect. Only the certified extracts from the commercial register and the publication texts in the Swiss Official Gazette of Commerce (SOGC) are binding.

 

Die Gelben Seiten - The Yellow Pages - Les Pages Jaunes - Le Pagine Gialle powered by HELP.CH ®
Copyright © 1996-2024 HELP Media Inc., Thurgauerstrasse 40, CH-8050 Zurich, Switzerland. All data with­out guar­antee. All rights reserved. Terms of use